These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2884736)

  • 1. Evaluation of the Chernoff/Kavlock test for developmental toxicity. Proceedings of the Workshop on the Chernoff/Kavlock Short Term In Vivo Developmental Toxicity Test. Cincinnati, Ohio, May 20 and 21, 1986.
    Teratog Carcinog Mutagen; 1987; 7(1):1-127. PubMed ID: 2884736
    [No Abstract]   [Full Text] [Related]  

  • 2. Currently used alternatives to the Chernoff-Kavlock short-term in vivo reproductive toxicity assay.
    Christian MS; Hoberman AM; Lochry EA
    Teratog Carcinog Mutagen; 1987; 7(1):65-71. PubMed ID: 2884744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Workshop on the Chernoff/Kavlock preliminary developmental toxicity test.
    Hardin BD; Becker RA; Kavlock RJ; Seidenberg JM; Chernoff N
    Teratog Carcinog Mutagen; 1987; 7(1):119-27. PubMed ID: 2884739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An indirect assessment of the Chernoff/Kavlock assay.
    Palmer AK
    Teratog Carcinog Mutagen; 1987; 7(1):95-106. PubMed ID: 2884748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for the statistical analysis of Chernoff/Kavlock test data.
    Burg JR; Hardin BD
    Teratog Carcinog Mutagen; 1987; 7(1):49-54. PubMed ID: 2884742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the use of neonatal birth weight, growth, viability, and survival data for predicting developmental neurotoxicity: a survey of the literature.
    Goldey ES; Tilson HA; Crofton KM
    Neurotoxicol Teratol; 1995; 17(3):313-32. PubMed ID: 7542737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recommended protocol for the Chernoff/Kavlock preliminary developmental toxicity test and a proposed method for assigning priority scores based on results of that test.
    Hardin BD
    Teratog Carcinog Mutagen; 1987; 7(1):85-94. PubMed ID: 2884747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A summary of the results of 55 chemicals screened for developmental toxicity in mice.
    Seidenberg JM; Becker RA
    Teratog Carcinog Mutagen; 1987; 7(1):17-28. PubMed ID: 2884740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of maternal and developmental toxicity. Proceedings of the consensus workshop. Rockville, Maryland, May 12-14, 1986.
    Teratog Carcinog Mutagen; 1987; 7(3):201-338. PubMed ID: 2888200
    [No Abstract]   [Full Text] [Related]  

  • 10. The Chernoff-Kavlock assay: its validation and application in rats.
    Wickramaratne GA
    Teratog Carcinog Mutagen; 1987; 7(1):73-83. PubMed ID: 2884746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design considerations in screening for behavioral teratogens: results of the Collaborative Behavioral Teratology Study. Proceedings of a conference. September 3-6, 1985, Cincinnati, Ohio.
    Neurobehav Toxicol Teratol; 1985; 7(6):537-789. PubMed ID: 3835449
    [No Abstract]   [Full Text] [Related]  

  • 12. Physicochemical and graph theoretical descriptors in developmental toxicity SAR: a comparative study.
    Macina OT; Sussman NB; Claycamp HG; Grant SG
    SAR QSAR Environ Res; 2001 Feb; 11(5-6):345-62. PubMed ID: 11328709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective analysis of developmental toxicity studies in rat and rabbit: what is the added value of the rabbit as an additional test species?
    Janer G; Slob W; Hakkert BC; Vermeire T; Piersma AH
    Regul Toxicol Pharmacol; 2008 Mar; 50(2):206-17. PubMed ID: 18171599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Background for two perspectives on the status and prospects of in vitro and short-term prescreening tests for developmental toxicity hazard potential.
    Welsch F
    Teratology; 1996 Jun; 53(6):332-3. PubMed ID: 8910977
    [No Abstract]   [Full Text] [Related]  

  • 15. Application of the preliminary developmental toxicity screen for chemical hazard identification under the Toxic Substances Control Act.
    Francis EZ; Farland WH
    Teratog Carcinog Mutagen; 1987; 7(1):107-17. PubMed ID: 2884738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evaluation of an in vivo teratology screen.
    Kavlock RJ; Short RD; Chernoff N
    Teratog Carcinog Mutagen; 1987; 7(1):7-16. PubMed ID: 2884745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Struggles for equivalence: in vitro developmental toxicity model evolution in pharmaceuticals in 2006.
    Chapin R; Stedman D; Paquette J; Streck R; Kumpf S; Deng S
    Toxicol In Vitro; 2007 Dec; 21(8):1545-51. PubMed ID: 17137747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using historical controls in the analysis of developmental toxicity data.
    Ryan L
    Biometrics; 1993 Dec; 49(4):1126-35. PubMed ID: 8117906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ culture of the fetal mouse palate for screening the developmental toxicity of chemicals: a validation study.
    Kosazuma T; Hashimoto S; Ohno H; Chou MJ; Shiota K
    Congenit Anom (Kyoto); 2004 Jun; 44(2):60-71. PubMed ID: 15198718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro tests in screening teratogens: considerations to aid the validation process.
    Kimmel GL
    Prog Clin Biol Res; 1985; 163C():259-63. PubMed ID: 3991628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.